Job Taylor

Oppenheimer & Co analysts Bret Holley, Matthew Lowe, Job Taylor and Brian Abrahams maintained their Outperform rating for shares of ArQule Inc (Nasdaq: ARQL), with a price target of $11 per share. The analysts said that they expect ArQule Inc to initiate a ph.III trial of '197+Tarceva in non-...